| Product Code: ETC13179085 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Rare Biomarkers Specimen Collection and Stabilization Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Rare Biomarkers Specimen Collection and Stabilization Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, 2021 & 2031F |
3.3 North America Rare Biomarkers Specimen Collection and Stabilization Market - Industry Life Cycle |
3.4 North America Rare Biomarkers Specimen Collection and Stabilization Market - Porter's Five Forces |
3.5 North America Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 North America Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.8 North America Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Specimen, 2021 & 2031F |
3.9 North America Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Nucleic Acid and other Biomolecules, 2021 & 2031F |
3.10 North America Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 North America Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 North America Rare Biomarkers Specimen Collection and Stabilization Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Rare Biomarkers Specimen Collection and Stabilization Market Trends |
6 North America Rare Biomarkers Specimen Collection and Stabilization Market, 2021 - 2031 |
6.1 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Circulating Cell Free DNA (ccfDNA), 2021 - 2031 |
6.1.3 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Circulating Tumor Cells (CTCs), 2021 - 2031 |
6.1.4 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Exosomes/Extracellular Vesicles, 2021 - 2031 |
6.2 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Product, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Isolation Kits and Reagents, 2021 - 2031 |
6.2.3 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Blood Collection Tubes, 2021 - 2031 |
6.2.4 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Systems, 2021 - 2031 |
6.3 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Specimen, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Serum/Plasma, 2021 - 2031 |
6.3.3 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Nucleic Acid and other Biomolecules, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By RNA, 2021 - 2031 |
6.4.3 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By DNA, 2021 - 2031 |
6.4.4 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Application, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By NIPT, 2021 - 2031 |
6.5.3 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.5.4 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Transcriptomics, 2021 - 2031 |
6.5.5 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Pharmacogenomics, 2021 - 2031 |
6.5.6 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Transplant Rejection, 2021 - 2031 |
6.5.7 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Population Screening, 2021 - 2031 |
6.5.8 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Cardiovascular Dieases, 2021 - 2031 |
6.5.9 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By End use, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.6.3 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Perinatal Clinics, 2021 - 2031 |
6.6.4 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Public Health Labs, 2021 - 2031 |
6.6.5 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Private or Commercial Labs, 2021 - 2031 |
6.6.6 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Physician Labs, 2021 - 2031 |
6.6.7 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
6.6.8 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Rare Biomarkers Specimen Collection and Stabilization Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Canada Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Rest of North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 North America Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Product, 2021 & 2031F |
7.3.1 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3.2 Canada Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3.3 Rest of North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Specimen, 2021 - 2031 |
7.4.1 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Specimen, 2021 - 2031 |
7.4.2 Canada Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Specimen, 2021 - 2031 |
7.4.3 Rest of North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Specimen, 2021 - 2031 |
7.5 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Nucleic Acid and other Biomolecules, 2021 - 2031 |
7.5.1 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Nucleic Acid and other Biomolecules, 2021 - 2031 |
7.5.2 Canada Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Nucleic Acid and other Biomolecules, 2021 - 2031 |
7.5.3 Rest of North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Nucleic Acid and other Biomolecules, 2021 - 2031 |
7.6 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Application, 2021 - 2031 |
7.6.1 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Application, 2021 - 2031 |
7.6.2 Canada Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Application, 2021 - 2031 |
7.6.3 Rest of North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7 North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By End use, 2021 - 2031 |
7.7.1 United States (US) Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By End use, 2021 - 2031 |
7.7.2 Canada Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By End use, 2021 - 2031 |
7.7.3 Rest of North America Rare Biomarkers Specimen Collection and Stabilization Market, Revenues & Volume, By End use, 2021 - 2031 |
8 North America Rare Biomarkers Specimen Collection and Stabilization Market Key Performance Indicators |
9 North America Rare Biomarkers Specimen Collection and Stabilization Market - Export/Import By Countries Assessment |
10 North America Rare Biomarkers Specimen Collection and Stabilization Market - Opportunity Assessment |
10.1 North America Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 North America Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Product, 2021 & 2031F |
10.4 North America Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Specimen, 2021 & 2031F |
10.5 North America Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Nucleic Acid and other Biomolecules, 2021 & 2031F |
10.6 North America Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Application, 2021 & 2031F |
10.7 North America Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By End use, 2021 & 2031F |
11 North America Rare Biomarkers Specimen Collection and Stabilization Market - Competitive Landscape |
11.1 North America Rare Biomarkers Specimen Collection and Stabilization Market Revenue Share, By Companies, 2022 |
11.2 North America Rare Biomarkers Specimen Collection and Stabilization Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here